DrugPatentWatch Database Preview
Drugs in Development Information for Plinabulin
» See Plans and Pricing
What is the development status for investigational drug Plinabulin?
Plinabulin is an investigational drug.
There have been 8 clinical trials for Plinabulin.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2016.
The most common disease conditions in clinical trials are Neutropenia, Lung Neoplasms, and Carcinoma, Non-Small-Cell Lung. The leading clinical trial sponsors are BeyondSpring Pharmaceuticals Inc., National Cancer Institute (NCI), and Lyudmila Bazhenova, M.D.
There are fifteen US patents protecting this investigational drug and ninety-one international patents.
Summary for Plinabulin
| US Patents | 15 |
| International Patents | 91 |
| US Patent Applications | 23 |
| WIPO Patent Applications | 134 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-06-01) |
| Vendors | 43 |
Recent Clinical Trials for Plinabulin
| Title | Sponsor | Phase |
|---|---|---|
| A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer | Jyoti Malhotra | Phase 1/Phase 2 |
| Plinabulin iv Solution in Prevention of TAC Induced Neutropenia | BeyondSpring Pharmaceuticals Inc. | Phase 2 |
| Plinabulin vs. Pegfilgrastim in Reducing the Duration of Severe Neutropenia in Breast Cancer Patients Receiving Myelosuppressive Chemotherapy With Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) | BeyondSpring Pharmaceuticals Inc. | Phase 2/Phase 3 |
Clinical Trial Summary for Plinabulin
Top disease conditions for Plinabulin
Top clinical trial sponsors for Plinabulin
US Patents for Plinabulin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Plinabulin | Start Trial | Method of treating a brain tumor | BeyondSpring Pharmaceuticals, Inc. (New York, NY) | Start Trial |
| Plinabulin | Start Trial | Plinabulin compositions | BeyondSpring Pharmaceuticals, Inc. (New York, NY) | Start Trial |
| Plinabulin | Start Trial | Method of treating cancer associated with a RAS mutation | BeyondSpring Pharmaceuticals, Inc. (New York, NY) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Plinabulin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Plinabulin | Australia | 2016229295 | 2035-03-06 | Start Trial |
| Plinabulin | Brazil | 112017018964 | 2035-03-06 | Start Trial |
| Plinabulin | Canada | 2978679 | 2035-03-06 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
